Report Detail
Global Infection Prevention and Enteral Access Market Insights, Forecast to 2025
- RnM2700443 |
- 14 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.
Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis and chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth.
Moreover, increasing RandD investments and untapped market opportunities in developing countries increase opportunities for the market growth.
The global Infection Prevention and Enteral Access market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Infection Prevention and Enteral Access market based on company, product type, end user and key regions.
This report studies the global market size of Infection Prevention and Enteral Access in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Infection Prevention and Enteral Access in these regions.
This research report categorizes the global Infection Prevention and Enteral Access market by top players/brands, region, type and end user. This report also studies the global Infection Prevention and Enteral Access market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cook Medical
Medtronic plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA
Market size by Product
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Market size by End User
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Infection Prevention and Enteral Access market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Infection Prevention and Enteral Access market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Infection Prevention and Enteral Access companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Infection Prevention and Enteral Access submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Infection Prevention and Enteral Access are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Infection Prevention and Enteral Access market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Infection Prevention and Enteral Access Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Product
- 1.4.2 Enteral Feeding Pumps
- 1.4.3 Enteral Feeding Tubes
- 1.4.4 Administration Reservoirs
- 1.4.5 Giving Sets
- 1.4.6 Enteral Syringes
- 1.5 Market by End User
- 1.5.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Gastroenterology
- 1.5.4 Diabetes
- 1.5.5 Neurological Disorders
- 1.5.6 Hypermetabolism
- 1.5.7 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Infection Prevention and Enteral Access Market Size
- 2.1.1 Global Infection Prevention and Enteral Access Revenue 2014-2025
- 2.1.2 Global Infection Prevention and Enteral Access Sales 2014-2025
- 2.2 Infection Prevention and Enteral Access Growth Rate by Regions
- 2.2.1 Global Infection Prevention and Enteral Access Sales by Regions
- 2.2.2 Global Infection Prevention and Enteral Access Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Infection Prevention and Enteral Access Sales by Manufacturers
- 3.1.1 Infection Prevention and Enteral Access Sales by Manufacturers
- 3.1.2 Infection Prevention and Enteral Access Sales Market Share by Manufacturers
- 3.1.3 Global Infection Prevention and Enteral Access Market Concentration Ratio (CR5 and HHI)
- 3.2 Infection Prevention and Enteral Access Revenue by Manufacturers
- 3.2.1 Infection Prevention and Enteral Access Revenue by Manufacturers (2014-2019)
- 3.2.2 Infection Prevention and Enteral Access Revenue Share by Manufacturers (2014-2019)
- 3.3 Infection Prevention and Enteral Access Price by Manufacturers
- 3.4 Infection Prevention and Enteral Access Manufacturing Base Distribution, Product Types
- 3.4.1 Infection Prevention and Enteral Access Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Infection Prevention and Enteral Access Product Type
- 3.4.3 Date of International Manufacturers Enter into Infection Prevention and Enteral Access Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Infection Prevention and Enteral Access Sales by Product
- 4.2 Global Infection Prevention and Enteral Access Revenue by Product
- 4.3 Infection Prevention and Enteral Access Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Infection Prevention and Enteral Access Breakdown Data by End User
6 North America
- 6.1 North America Infection Prevention and Enteral Access by Countries
- 6.1.1 North America Infection Prevention and Enteral Access Sales by Countries
- 6.1.2 North America Infection Prevention and Enteral Access Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Infection Prevention and Enteral Access by Product
- 6.3 North America Infection Prevention and Enteral Access by End User
7 Europe
- 7.1 Europe Infection Prevention and Enteral Access by Countries
- 7.1.1 Europe Infection Prevention and Enteral Access Sales by Countries
- 7.1.2 Europe Infection Prevention and Enteral Access Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Infection Prevention and Enteral Access by Product
- 7.3 Europe Infection Prevention and Enteral Access by End User
8 Asia Pacific
- 8.1 Asia Pacific Infection Prevention and Enteral Access by Countries
- 8.1.1 Asia Pacific Infection Prevention and Enteral Access Sales by Countries
- 8.1.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Infection Prevention and Enteral Access by Product
- 8.3 Asia Pacific Infection Prevention and Enteral Access by End User
9 Central & South America
- 9.1 Central & South America Infection Prevention and Enteral Access by Countries
- 9.1.1 Central & South America Infection Prevention and Enteral Access Sales by Countries
- 9.1.2 Central & South America Infection Prevention and Enteral Access Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Infection Prevention and Enteral Access by Product
- 9.3 Central & South America Infection Prevention and Enteral Access by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Infection Prevention and Enteral Access by Countries
- 10.1.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Countries
- 10.1.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Infection Prevention and Enteral Access by Product
- 10.3 Middle East and Africa Infection Prevention and Enteral Access by End User
11 Company Profiles
- 11.1 Cook Medical
- 11.1.1 Cook Medical Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Cook Medical Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Cook Medical Infection Prevention and Enteral Access Products Offered
- 11.1.5 Cook Medical Recent Development
- 11.2 Medtronic plc
- 11.2.1 Medtronic plc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Medtronic plc Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Medtronic plc Infection Prevention and Enteral Access Products Offered
- 11.2.5 Medtronic plc Recent Development
- 11.3 Boston Scientific Corporation
- 11.3.1 Boston Scientific Corporation Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Products Offered
- 11.3.5 Boston Scientific Corporation Recent Development
- 11.4 CONMED Corporation
- 11.4.1 CONMED Corporation Company Details
- 11.4.2 Company Business Overview
- 11.4.3 CONMED Corporation Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 CONMED Corporation Infection Prevention and Enteral Access Products Offered
- 11.4.5 CONMED Corporation Recent Development
- 11.5 CORPAK MedSystems
- 11.5.1 CORPAK MedSystems Company Details
- 11.5.2 Company Business Overview
- 11.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Products Offered
- 11.5.5 CORPAK MedSystems Recent Development
- 11.6 CR Bard
- 11.6.1 CR Bard Company Details
- 11.6.2 Company Business Overview
- 11.6.3 CR Bard Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 CR Bard Infection Prevention and Enteral Access Products Offered
- 11.6.5 CR Bard Recent Development
- 11.7 ALCOR Scientific
- 11.7.1 ALCOR Scientific Company Details
- 11.7.2 Company Business Overview
- 11.7.3 ALCOR Scientific Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 ALCOR Scientific Infection Prevention and Enteral Access Products Offered
- 11.7.5 ALCOR Scientific Recent Development
- 11.8 Pacific Hospital Supply
- 11.8.1 Pacific Hospital Supply Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Products Offered
- 11.8.5 Pacific Hospital Supply Recent Development
- 11.9 Teleflexorporated
- 11.9.1 Teleflexorporated Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Teleflexorporated Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Teleflexorporated Infection Prevention and Enteral Access Products Offered
- 11.9.5 Teleflexorporated Recent Development
- 11.10 Vygon SA
- 11.10.1 Vygon SA Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Vygon SA Infection Prevention and Enteral Access Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Vygon SA Infection Prevention and Enteral Access Products Offered
- 11.10.5 Vygon SA Recent Development
12 Future Forecast
- 12.1 Infection Prevention and Enteral Access Market Forecast by Regions
- 12.1.1 Global Infection Prevention and Enteral Access Sales Forecast by Regions 2019-2025
- 12.1.2 Global Infection Prevention and Enteral Access Revenue Forecast by Regions 2019-2025
- 12.2 Infection Prevention and Enteral Access Market Forecast by Product
- 12.2.1 Global Infection Prevention and Enteral Access Sales Forecast by Product 2019-2025
- 12.2.2 Global Infection Prevention and Enteral Access Revenue Forecast by Product 2019-2025
- 12.3 Infection Prevention and Enteral Access Market Forecast by End User
- 12.4 North America Infection Prevention and Enteral Access Forecast
- 12.5 Europe Infection Prevention and Enteral Access Forecast
- 12.6 Asia Pacific Infection Prevention and Enteral Access Forecast
- 12.7 Central & South America Infection Prevention and Enteral Access Forecast
- 12.8 Middle East and Africa Infection Prevention and Enteral Access Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Infection Prevention and Enteral Access Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Infection Prevention and Enteral Access . Industry analysis & Market Report on Infection Prevention and Enteral Access is a syndicated market report, published as Global Infection Prevention and Enteral Access Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Infection Prevention and Enteral Access market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
